Status:
COMPLETED
Agreement Among Expert Radiologists in Diagnosing Primary Liver Tumors by Magnetic Resonance Imaging (MRI)
Lead Sponsor:
University of Zurich
Collaborating Sponsors:
Harvard University
University Hospital, Essen
Conditions:
Neoplasms
Eligibility:
All Genders
18-90 years
Brief Summary
The purpose of this multicenter study is to evaluate the agreement among expert radiologists in interpreting magnetic resonance images (MRI) assessing common primary liver tumours in non-cirrhotic pat...
Detailed Description
Magnetic Resonance Imaging (MRI) is currently the method of choice for non-invasive diagnosis of primary liver tumors. However, differentiation of hepatocellular carcinoma (HCC) from adenoma and focal...
Eligibility Criteria
Inclusion
- Histopathological diagnosis of Hepatocellular Cancer (HCC), Adenoma and/or Focular nodular hyperplasia (FNH).
- Patients that received a pre-operative Magnetic Resonance Imaging (MRI).
- Patients that underwent liver resection with an intention to cure.
- Patient over 18 years of age
Exclusion
- Other histopathological diagnosis such as cysts and hemangiomas.
- Patient age less than 18 years of age.
Key Trial Info
Start Date :
October 1 2010
Trial Type :
OBSERVATIONAL
Allocation :
ACTUAL
End Date :
May 1 2012
Estimated Enrollment :
108 Patients enrolled
Trial Details
Trial ID
NCT01234701
Start Date
October 1 2010
End Date
May 1 2012
Last Update
May 28 2012
Active Locations (10)
Enter a location and click search to find clinical trials sorted by distance.
1
Harvard Medical School, Massachusetts General Hospital, and Beth Israel Deaconess Medical Center
Boston, Massachusetts, United States, 02117-0825
2
St. Louis University, Liver Center
St Louis, Missouri, United States, 63110-0250
3
University Hospital Strasbourg
Strasbourg, Cedex, France, 67098
4
University Hospital Essen
Essen, Germany, 45147